Quality & complianceOfficial

FDA classifies Preferred Pharmaceuticals artificial tears eye drop recall as Class II over sterility assurance

🇺🇸 FDA enforcement report · Wed 11 Nov 2026

The agency's enforcement report lists recall D-0158-2027 for Artificial Tears Lubricant Eye Drops, citing lack of assurance of sterility, with US nationwide distribution and the recall ongoing.

The US Food and Drug Administration has published a Class II recall entry for Artificial Tears Lubricant Eye Drops from Preferred Pharmaceuticals, Inc. in its enforcement report dated 11 November 2026. The recall is numbered D-0158-2027.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA enforcement report ↗

Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.